Tag: Biosintez

JSC “Biosintez”, a SUN PHARMA company – is one of Russia’s largest pharmaceutical companies. Sun Pharma is the fifth largest global generic pharmaceutical company with global revenues of US$ 4.3 billion. With presence in more than 150 countries, Sun Pharma is Indian pharmaceutical company known for its high quality, speciality generic medicines trusted by patients & health professionals worldwide. JSC “Biosintez” today sells products in 12 countries of the CIS. The history of JSC “Biosintez” begins in 1955, when on the outskirts of the city of Penza several buildings of the future plant began to grow . After 4 years, the first production enterprise was launched in October 1959 – biomitsin antibiotic and vitamin B12.

Sun Pharma Commissioned Production Line at Biosintez

Sun Pharma (the Netherlands, owned by India’s Sun Pharmaceutical Industries Ltd.) has commissioned a production line for making solid peroral tablets with an annual capacity of 2 billion tablets at th...

Sun Pharma Raise Stake in Biosintez to 96.96%

Sun Pharmaceutical Industries on Wednesday said it has increased stake in Russia's PJSC Biosintez to 96.96 per cent with the purchase of additional shares worth over Rs 22 crore. The company's whol...

Biosintez will launch its new production facility in September 2018

Biosintez is one of the largest Russian pharma manufacturers. Its products range from substances to finished medicines, including tablets, ointments, suppositories, powders for injections, injection and infusion solutions.

Biosintez is establishing new facility to manufacture solid dosage forms

In November 2017, Biosintez PJSC signed a contract to build new facility for manufacturing solid dosage forms

Sun Pharma modernizes Biosintez plant in Penza

sun pharma
Biosintez plant gets a new lease on life. At the end of November 2016, the Indian pharmaceutical company bought shares of this Penza-based enterprise. The transformations under way on the plant were p...

Biotec announces sale of Biosintez to Sun Pharma

Biotec group, one of the leading Russian pharmaceutical companies, specializing on production, wholesale and retail distribution of pharmaceuticals, entered into the agreement for the sale of 85,1% of...